Business1% match
Spyglass Pharma Establishes Expanded Headquarters in Irvine, Prepares for Glaucoma Implant Launch
The Biopharmaceutical Company Has Tripled Its Capacity with a New Facility as It Progresses Its Lead Product Toward a 2029 Market Introduction and Expands Its Treatment Pipeline.
Sep 7, 2026